Aerospace Sector Drives Advanced Manufacturing Transformation in Mexico Broadstone BNL Q1 2026 Earnings Beat Revenue NA EPS 024 Alector ALEC Reports Strong Q1 2026 Revenue NA EPS Beats Democrats Eye Conservative Bernie Candidates in Red States Potential Policy Shifts Ahead Bitcoin ETFs See 1 Billion Outflows as Capital Rotates into HYPE SOL XRP SafeHaven Currencies Yen and Franc Rally Amid DeepSeek AI Sector Disruption Saudi Arabias Vision 2030 Spending Spree Faces Fiscal Reality Check Anthropic Surprises Markets with Profit Projection Ahead of Potential IPO China Urges APEC Cooperation as Commerce Minister Skips Opening Meeting Due to Urgent Business Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales GSBC Q1 2026 Earnings EPS Surges 20 Above Estimates Amid Prudent Banking Operations GNLX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline BBY Q1 2026 Earnings EPS Beats Estimates by Nearly 5 Stock Rises Essent Group Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment GPRK Q1 2026 Earnings Solid EPS Performance Amid Limited Consensus Data FGBIP Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Remains Stable Click Holdings Limited CLIK Surges Nearly 10 Amid Improved Market Sentiment Neumora Therapeutics NMRA Holds Steady at 185 Amid Mixed Sentiment Woori Financial Group WF Faces Pressure Down 289 Amid Sector Weakness Edgewise Therapeutics EWTX Holds Steady Near Support as Consolidation Continues Stag Industrial Slips Fractionally Amid Consolidation Near Key Moving Averages Goa Tourism Shift Foreign Arrivals Halve as Domestic Market Surges New York Fed Finds Ongoing Student Loan Woes in First Quarter Exponent EXPO Reports Strong Q1 2026 Revenue NA EPS Beats Installed IBP Stock Today Drops 172 Key Support at 19252 20260513 Yum China YUMC Fell 102 Is a Recovery Ahead 20260515 Traders Bet on IonQ Micron and Anduril as Potential Next Targets for US Government Stake Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues Maze Therapeutics MAZE Edges Higher as Stock Consolidates Near Resistance